These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34936303)

  • 1. Propofol Ameliorates the Proliferation and Epithelial-Mesenchymal Transition of Hepatoma Carcinoma Cells via Non-Coding RNA Activated by DNA Damage (NORAD)/microRNA (miR)-556-3p/Migration and Invasion Enhancer 1 (MIEN1) Axis.
    Liu Y; Wang X; Li H; Guan E; Luo K
    J Environ Pathol Toxicol Oncol; 2021; 40(4):87-97. PubMed ID: 34936303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p/LIMK1 axis.
    Wang D; Xing N; Yang T; Liu J; Zhao H; He J; Ai Y; Yang J
    Cancer Med; 2020 Oct; 9(19):7218-7230. PubMed ID: 32767662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p.
    Wang B; Xu L; Zhang J; Cheng X; Xu Q; Wang J; Mao F
    Biomed Pharmacother; 2020 Sep; 129():110268. PubMed ID: 32563146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
    Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
    Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA-non-coding RNA activated by DNA damage inhibition suppresses hepatic stellate cell activation via microRNA-495-3p/sphingosine 1-phosphate receptor 3 axis.
    Zou L; Shi C; Wang D; Cheng J; Wang Q; Wang L; Yang G
    Bioengineered; 2022 Mar; 13(3):6150-6162. PubMed ID: 35200103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long noncoding RNA noncoding RNA activated by DNA damage (NORAD)-microRNA-496-Interleukin-33 axis affects carcinoma-associated fibroblasts-mediated gastric cancer development.
    Huang C; Liu J; He L; Wang F; Xiong B; Li Y; Yang X
    Bioengineered; 2021 Dec; 12(2):11738-11755. PubMed ID: 34895039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1.
    He C; Liu Z; Jin L; Zhang F; Peng X; Xiao Y; Wang X; Lyu Q; Cai X
    Cell Physiol Biochem; 2018; 48(5):1928-1941. PubMed ID: 30092578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA NORAD, sponging miR-363-3p, promotes invasion and EMT by upregulating PEAK1 and activating the ERK signaling pathway in NSCLC cells.
    Geng Q; Li Z; Li X; Wu Y; Chen N
    J Bioenerg Biomembr; 2021 Jun; 53(3):321-332. PubMed ID: 33742335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA NORAD promotes proliferation, migration and angiogenesis of hepatocellular carcinoma cells through targeting miR-211-5p/FOXD1/VEGF-A axis.
    Sun DS; Guan CH; Wang WN; Hu ZT; Zhao YQ; Jiang XM
    Microvasc Res; 2021 Mar; 134():104120. PubMed ID: 33309645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
    Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
    Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA TTN antisense RNA 1 facilitates hepatocellular carcinoma progression via regulating miR-139-5p/SPOCK1 axis.
    Zhu X; Jiang S; Wu Z; Liu T; Zhang W; Wu L; Xu L; Shao M
    Bioengineered; 2021 Dec; 12(1):578-588. PubMed ID: 33517826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA NORAD exhaustion represses prostate cancer progression through inhibiting TRIP13 expression via competitively binding to miR-495-3p.
    Chen F; Liu L; Wang S
    Cancer Cell Int; 2020; 20():323. PubMed ID: 32694945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA KCNQ1OT1 contributes to the cisplatin resistance of tongue cancer through the KCNQ1OT1/miR-124-3p/TRIM14 axis.
    Qiao CY; Qiao TY; Jin H; Liu LL; Zheng MD; Wang ZL
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):200-212. PubMed ID: 31957833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis.
    Jin J; Liu H; Jin M; Li W; Xu H; Wei F
    Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer.
    Li H; Wang X; Wen C; Huo Z; Wang W; Zhan Q; Cheng D; Chen H; Deng X; Peng C; Shen B
    Mol Cancer; 2017 Nov; 16(1):169. PubMed ID: 29121972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Noncoding RNA
    Gong X; Zhu Z
    Cancer Biother Radiopharm; 2020 Jun; 35(5):387-396. PubMed ID: 32315535
    [No Abstract]   [Full Text] [Related]  

  • 17. Silencing the lncRNA NORAD inhibits EMT of head and neck squamous cell carcinoma stem cells via miR‑26a‑5p.
    Hu W; Zhao Y; Su L; Wu Z; Jiang W; Jiang X; Liu M
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34435652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
    Qiu HB; Yang K; Yu HY; Liu M
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA NORAD inhibition upregulates microRNA-323a-3p to suppress tumorigenesis and development of breast cancer through the PUM1/eIF2 axis.
    Shi P; Zhang J; Li X; Li W; Li H; Fu P
    Cell Cycle; 2021 Jul; 20(13):1295-1307. PubMed ID: 34125645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long noncoding RNA NORAD enhances the TGF-β pathway to promote hepatocellular carcinoma progression by targeting miR-202-5p.
    Yang X; Cai JB; Peng R; Wei CY; Lu JC; Gao C; Shen ZZ; Zhang PF; Huang XY; Ke AW; Shi GM; Fan J
    J Cell Physiol; 2019 Jul; 234(7):12051-12060. PubMed ID: 30537113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.